Expansion opportunities Cryoport has recently expanded facilities in France and Western Europe, signaling a push into European markets and potential needs for scalable cold chain logistics, regulatory-compliant storage, and regional service coverage.

Cold chain modernization Launches of HE 800 C freezer and Cryoport Express Cryogenic HV3 Shipping System indicate a focus on advanced temperature-controlled shipping capabilities, offering opportunities to upsell enhanced shippers, monitoring, and integrated logistics solutions.

Strategic partnerships Recent collaboration with TMRW Life Sciences for secure specimen management suggests demand for end-to-end turnkey solutions combining storage, transport, and data integration—opening doors to cross-sell to fertility and biobanking clients.

Integrated solutions IntegriCell cryopreservation services and integration with Verismo Therapeutics’ processes point to potential for expanded service offerings, QA/system integration, and global quality management support for additional clinical programs.

Awards and credibility Winning the 2025 CPHI Pharma Award for Supply Chain Excellence enhances credibility with pharma and biotech customers, providing a platform to pursue larger contracts and ongoing supply chain outsourcing opportunities.